...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith-Oncology Pipeline
6
Mar 16, 2021 08:18AM
9
Mar 18, 2021 03:12PM
6
Mar 18, 2021 04:01PM
3
Mar 18, 2021 05:10PM
6
Mar 18, 2021 06:27PM
2
Mar 19, 2021 06:49AM
4
Mar 19, 2021 11:19AM
5
Mar 19, 2021 11:23AM
6
Mar 19, 2021 11:57AM
2
Mar 22, 2021 04:08PM
3
Mar 22, 2021 05:34PM
2
Mar 23, 2021 05:33AM
5
Mar 23, 2021 07:54AM

As there currently isn't any real market for Zenith other than the OTC I would say that the value is what someone would pay for a LARGE  # of shares, not the paltry few thousand that trade daily.

Market Cap is just math. Shares outstanding x price.  It's not a guesstimate of what people hope/think the company might be worth.  Some folks think the ZHCLF price is artifically low, but if just a handful of buyers thought it was a bargain, the price would zoom up because of the low liquidity. IMO the price reflects the untrue rumours that come and go, and the lack of confidence that we will see "unlocked shareholder value" in our pockets anytime in the foreseeable future.

 

8
Mar 23, 2021 01:45PM
4
Mar 23, 2021 02:24PM
2
Mar 23, 2021 03:27PM
2
Mar 23, 2021 04:33PM
Share
New Message
Please login to post a reply